|
Volumn 37, Issue 2, 2005, Pages 956-957
|
Chemotherapy for posttransplant lymphoproliferative disorder: The Israel Penn International Transplant Tumor Registry Experience
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACEPROMAZINE;
ANTINEOPLASTIC AGENT;
CD20 ANTIBODY;
CYCLOPHOSPHAMIDE;
CYTARABINE DERIVATIVE;
DOXORUBICIN;
METHOTREXATE;
MONOCLONAL ANTIBODY;
VINCRISTINE;
ADULT;
B LYMPHOCYTE;
CANCER CHEMOTHERAPY;
CANCER RECURRENCE;
CANCER REGISTRY;
CANCER SURVIVAL;
CAUCASIAN;
CONFERENCE PAPER;
CONTROLLED STUDY;
DEMOGRAPHY;
FEMALE;
HEART TRANSPLANTATION;
HUMAN;
INFORMATION PROCESSING;
KIDNEY TRANSPLANTATION;
LIVER TRANSPLANTATION;
LUNG TRANSPLANTATION;
LYMPHOPROLIFERATIVE DISEASE;
MAJOR CLINICAL STUDY;
MALE;
MORTALITY;
ORGAN TRANSPLANTATION;
PANCREAS TRANSPLANTATION;
POSTOPERATIVE COMPLICATION;
PRIORITY JOURNAL;
|
EID: 17844387623
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/j.transproceed.2004.12.124 Document Type: Conference Paper |
Times cited : (58)
|
References (5)
|